ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1707

Development and Delivery of Continuing Education Interventions Promoting Shared Decision Making in Rheumatoid Arthritis

Richard Martin1, Marianna Shershneva2 and Lily Zurkovsky3, 1Michigan State University College of Human Medicine, Grand Rapids, MI, 2Senior Administrative Program Specialist, Office of Continuing Professional Development University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Forefront Collaborative, Carmel, IN

Meeting: ACR Convergence 2020

Keywords: Decision analysis, Disease-Modifying Antirheumatic Drugs (Dmards), education, medical, education, patient, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Professional Education Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: A core CMS policy goal is to improve patient experience by encouraging patient-centered care and shared decision making (SDM).  However, SDM techniques are underutilized in rheumatology practice1.  We created two continuing medical education (CME) activities that present ACR guidelines, treat-to-target (T2T) concepts, and SDM as vehicles to increase the equity of the provision of healthcare2 for rheumatoid arthritis (RA).

Methods: A live workshop (LW) and an online course (OC) were designed to explain ACR RA guidelines, treat-to-target concepts as well as to demonstrate and practice using SDM with the goal of aligning treatment with patient goals.  In interviews with four rheumatologists, we identified three ‘swimming lanes’ in the RA patient experience of choosing DMARDs.   This led to the development of Option Table Patient Decision Aids (PtDAs) presenting three common choice sets for a patient considering starting their 1st, 2nd or 3rd DMARD.  PtDAs provide specific probabilities about outcomes to structure clinical discussion with patients and their deliberation after the visit. See figure 1.

Nearly half of the 90-minute workshop for rheumatology providers was focused on teaching SDM. Learners listened to a skill-oriented explanation of SDM as a multi-step interviewing procedure based on observable domains3. They then viewed a demonstration of SDM by a faculty and a patient-actor.  A PtDA was used to support the clinical encounter by providing facts about options and structuring comparison of attributes of the DMARDs in the choice set being considered.  Finally, learners practiced a new SDM encounter supported by a PtDA in pairs followed by debriefing.

A 75-minute online activity was developed based on the recorded workshop and disseminated on myCME.com to a broad audience of rheumatology providers and other clinicians.

Results: There were 54 participants in the LW and 1337 in the OC.  After the interventions, 92% and 93% believed they could effectively engage in T2T-SDM, 78% and 93% believed the PtDA enhanced their learning of SDM.  Comparing pre-post knowledge assessment, both groups (LW 56 to 82% and OC 57 to 99%) increased their ability to recognize patient statements consistent with being engaged in SDM. 59% of LW and 43% of OC intended to make changes in their practice as a result of participation

Conclusion: Both LW and OC reinforced positive attitudes towards learning about T2T and SDM.  Modeling and active practice of SDM using a PtDA influenced beliefs, knowledge, and intentions to change practice related to SDM.

References: 

1. Martin RW et al. Patient Beliefs and Preference to Initiate a Proposed Medication in Rheumatoid Arthritis. Arthritis Rheumatol 2017;69 (suppl 10).
2.  Wennberg JE Tracking Medicine: A Researcher’s Quest to Understand Health Care. Oxford University Press, USA. 2010 1st edition. pp209-264.
3.  Elwyn G, et al. Shared decision making: developing the OPTION scale for measuring patient involvement. BMJ Quality & Safety 2003;12:93-99.

Option Table Decision Aid: For a Patient With Rheumatoid Arthritis Considering Starting Their Third DMARD


Disclosure: R. Martin, Abbvie, 9, Amgen, 9, Eli Lilly, 9; M. Shershneva, Eli Lilly, 2; L. Zurkovsky, Teva, 1.

To cite this abstract in AMA style:

Martin R, Shershneva M, Zurkovsky L. Development and Delivery of Continuing Education Interventions Promoting Shared Decision Making in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/development-and-delivery-of-continuing-education-interventions-promoting-shared-decision-making-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-delivery-of-continuing-education-interventions-promoting-shared-decision-making-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology